Binding molecules capable of neutralizing rabies virus and uses thereof
US7579446B2 · kind B2 · utility
41Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2006 |
| Grant date | Aug 25, 2009 |
| Priority date | — |
| Expiry date | Oct 31, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/20122
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides binding molecules that specifically bind to rabies virus and are capable of neutralizing the virus. The invention further provides nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from rabies virus. Preferably, they can be used in the post-exposure prophylaxis of rabies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.